P

PharmNovo

8 employees

PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CNS
Pharmacology
Bioscience
Pharmaceutical
Delta opioid receptor
Proteins
Neurology
Chemistry
Health Care
DOR agonists
BioPharma
Chronic Pain Treatment

Date founded

2008

Funding rounds raised

Total raised

$6.9M

from 6 investors over 6 rounds

P

PharmNovo raised $569K on July 15, 2022

Investors: Sciety

P

PharmNovo raised $6.9M on June 3, 2022

Investors: Karolinska Development, Sciety, Polynom Investment AB (publ) and Almi Invest

P

PharmNovo raised $2.5M on September 1, 2020

Investors: Sciety

FAQ